SCHEMBL710605

SCHEMBL710605

CC[n+]1c(/C=C/c2ccc(N(C)C)cc2)cccc1/C=C/c1ccc(N(C)C)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 9/20 0.66
KMT2A Q03164 9/20 0.66
RAB9A P51151 7/20 0.66
HTT P42858 4/20 0.66
SMN1; SMN2 Q16637 4/20 0.66
ALDH1A1 P00352 3/20 0.66
LMNA P02545 3/20 0.66
NPSR1 Q6W5P4 3/20 0.66
POLB P06746 2/20 0.66
BLM P54132 2/20 0.66
PPARG P37231 1/20 0.66
NCOA2 Q15596 1/20 0.66
NCOA1 Q15788 1/20 0.66
L3MBTL1 Q9Y468 1/20 0.66
NPC1 O15118 5/20 0.64
MAPT P10636 4/20 0.64
STAT3 P40763 1/20 0.64
APOBEC3A P31941 3/20 0.55
APOBEC3G Q9HC16 3/20 0.55
RELA Q04206 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL710606 1.00 MEN1 (0.66) MEN1KMT2ARAB9AHTTSMN1; SMN2
Hydrochloric Acid SCHEMBL710377 0.98 MEN1 (0.64) MEN1KMT2ARAB9AHTTSMN1; SMN2
Iodide SCHEMBL8072628 0.98 MEN1 (0.68) MEN1KMT2ARAB9AHTTSMN1; SMN2
Iodide SCHEMBL8072629 0.98 MEN1 (0.68) MEN1KMT2ARAB9AHTTSMN1; SMN2
Hydrochloric Acid SCHEMBL710378 0.98 MEN1 (0.64) MEN1KMT2ARAB9AHTTSMN1; SMN2
SCHEMBL712502 0.85 MEN1 (0.56) MEN1KMT2ARAB9AHTTSMN1; SMN2
SCHEMBL712503 0.85 MEN1 (0.56) MEN1KMT2ARAB9AHTTSMN1; SMN2
Hydrochloric Acid SCHEMBL711395 0.84 MEN1 (0.55) MEN1KMT2ARAB9AHTTSMN1; SMN2
Hydrochloric Acid SCHEMBL711394 0.84 MEN1 (0.55) MEN1KMT2ARAB9AHTTSMN1; SMN2
SCHEMBL13126940 0.83 MEN1 (0.56) MEN1KMT2ARAB9AHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0499693-B1 Method of differentiating erythroblasts from other cells by flow cytometry TOA MEDICAL ELECTRONICS (JP) 1997-02-05 EP claimed
EP-0513762-B1 Reagent and method for analyzing cells in urine TOA MEDICAL ELECTRONICS (JP) 1996-09-04 EP claimed
EP-0483116-B1 Method of classifying leukocytes by flow cytometry and reagents used in the method TOA MEDICAL ELECTRONICS (JP) 1996-07-17 EP claimed
EP-0485945-B1 Method of classifying leukocytes by flow cytometry TOA MEDICAL ELECTRONICS (JP) 1996-06-05 EP claimed
EP-0268766-B1 METHOD OF CLASSIFYING LEUKOCYTES BY FLOW CYTOMETRY AND REAGENTS USED IN THE METHOD TOA MEDICAL ELECTRONICS CO., LTD. (JP) 1993-06-16 EP claimed
EP-0259834-B1 METHOD OF CLASSIFYING LEUCOCYTES BY FLOW CYTOMETRY TOA MEDICAL ELECTRONICS CO., LTD. (JP) 1992-08-12 EP claimed
US-8124626-B2 Methods of treating inflammations and infections with pyridinium salts MYCOSOL, INC. (US) 2012-02-28 US disclosed
US-7820696-B2 Compounds and methods for controlling fungi, bacteria and insects MYCOSOL, INC. (US) 2010-10-26 US disclosed
US-7820696-B2 Compounds and methods for controlling fungi, bacteria and insects MYCOSOL, INC. (US) 2010-10-26 US disclosed
US-7820696-B2 Compounds and methods for controlling fungi, bacteria and insects MYCOSOL, INC. (US) 2010-10-26 US disclosed
US-20100267716-A1 METHODS OF TREATING INFLAMMATIONS AND INFECTIONS WITH PYRIDINIUM SALTS KLEIN RICHARD B 2010-10-21 US disclosed
US-7547444-B1 Methods for controlling fungi and bacteria MYCOSOL, INC. (US) 2009-06-16 US disclosed
US-7547444-B1 Methods for controlling fungi and bacteria MYCOSOL, INC. (US) 2009-06-16 US disclosed
US-20070213299-A1 COMPOUNDS AND METHODS FOR CONTROLLING FUNGI, BACTERIA AND INSECTS MYCOSOL, INC. 2007-09-13 US disclosed
US-20070213299-A1 COMPOUNDS AND METHODS FOR CONTROLLING FUNGI, BACTERIA AND INSECTS MYCOSOL, INC. 2007-09-13 US disclosed
WO-2007086900-A2 STILBAZIUM RESEARCH ASSAYS MYCOSOL, INC. (US) 2007-08-02 WO disclosed
US-7220761-B2 Compounds and methods for controlling fungi, bacteria and insects MYCOSOL, INC. (US) 2007-05-22 US disclosed
US-7220761-B2 Compounds and methods for controlling fungi, bacteria and insects MYCOSOL, INC. (US) 2007-05-22 US disclosed
US-20040235898-A1 Compounds and methods for controlling fungi, bacteria and insects MYCOSOL, INC. 2004-11-25 US disclosed
US-20040224984-A1 Methods of treating inflammations and infections with pyridinium salts MYCOSOL, INC. 2004-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213299-A1 COMPOUNDS AND METHODS FOR CONTROLLING FUNGI, BACTERIA AND INSECTS BLVRB, PNPO, PLPBP MEN1 353/4885KMT2A 1264/4885RAB9A 3091/4885
US-20040235898-A1 Compounds and methods for controlling fungi, bacteria and insects BLVRB, PNPO, PLPBP MEN1 353/4885KMT2A 1264/4885RAB9A 3091/4885
US-20100267716-A1 METHODS OF TREATING INFLAMMATIONS AND INFECTIONS WITH PYRIDINIUM SALTS PNPO, PLPBP, TPMT MEN1 2265/4885KMT2A 3654/4885RAB9A 4725/4885
US-20040224984-A1 Methods of treating inflammations and infections with pyridinium salts PNPO, PLPBP, TPMT MEN1 2265/4885KMT2A 3654/4885RAB9A 4725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.